BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 38612572)

  • 21. Metabolomic profiles and microbiota of GDM offspring: The key for future perspective?
    Dessì A; Tognazzi C; Bosco A; Pintus R; Fanos V
    Front Pediatr; 2022; 10():941800. PubMed ID: 36275053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus.
    Pilszyk A; Niebrzydowska M; Pilszyk Z; Wierzchowska-Opoka M; Kimber-Trojnar Ż
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Gestational Effects of Maternal Bone Marker Molecules on Fetal Growth, Metabolism and Long-Term Metabolic Health: A Systematic Review.
    Dimas A; Politi A; Bargiota A; Panoskaltsis T; Vlahos NF; Valsamakis G
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia.
    Hufnagel A; Dearden L; Fernandez-Twinn DS; Ozanne SE
    J Endocrinol; 2022 Apr; 253(2):R47-R63. PubMed ID: 35258482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Regenerative Potential of Substance P.
    Redkiewicz P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal programming by androgen excess impairs liver lipid content and PPARg expression in adult rats.
    Silva AF; Abruzzese GA; Ferrer MJ; Heber MF; Ferreira SR; Cerrone GE; Motta AB
    J Dev Orig Health Dis; 2022 Jun; 13(3):300-309. PubMed ID: 34275515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanisms of Maternal Diabetes Effects on Fetal and Neonatal Surfactant.
    Yildiz Atar H; Baatz JE; Ryan RM
    Children (Basel); 2021 Apr; 8(4):. PubMed ID: 33917547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening.
    Hillier TA; Pedula KL; Ogasawara KK; Vesco KK; Oshiro CES; Lubarsky SL; Van Marter J
    N Engl J Med; 2021 Mar; 384(10):895-904. PubMed ID: 33704936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SP prevents T2DM complications by immunomodulation.
    Baek SM; Kim K; Kim S; Son Y; Hong HS; Yu SY
    Sci Rep; 2020 Oct; 10(1):16753. PubMed ID: 33028888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental function in maternal obesity.
    Kelly AC; Powell TL; Jansson T
    Clin Sci (Lond); 2020 Apr; 134(8):961-984. PubMed ID: 32313958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive Weight Gain Before and During Gestational Diabetes Mellitus Management: What Is the Impact?
    Barnes RA; Wong T; Ross GP; Griffiths MM; Smart CE; Collins CE; MacDonald-Wicks L; Flack JR
    Diabetes Care; 2020 Jan; 43(1):74-81. PubMed ID: 31690637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal obesity and gestational diabetes mellitus affect body composition through infancy: the PONCH study.
    Andersson-Hall UK; Järvinen EAJ; Bosaeus MH; Gustavsson CE; Hårsmar EJ; Niklasson CA; Albertsson-Wikland KG; Holmäng AB
    Pediatr Res; 2019 Feb; 85(3):369-377. PubMed ID: 30705398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine kinase and cardiovascular fetal programming in gestational diabetes mellitus.
    Silva L; Plösch T; Toledo F; Faas MM; Sobrevia L
    Biochim Biophys Acta Mol Basis Dis; 2020 Feb; 1866(2):165397. PubMed ID: 30699363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestational diabetes and maternal obesity are associated with epigenome-wide methylation changes in children.
    Hjort L; Martino D; Grunnet LG; Naeem H; Maksimovic J; Olsson AH; Zhang C; Ling C; Olsen SF; Saffery R; Vaag AA
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Interplay Between Nutrition and Stress in Pregnancy: Implications for Fetal Programming of Brain Development.
    Lindsay KL; Buss C; Wadhwa PD; Entringer S
    Biol Psychiatry; 2019 Jan; 85(2):135-149. PubMed ID: 30057177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
    Bright FM; Byard RW; Vink R; Paterson DS
    Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Fetal Adipokines and Child Behavioral Problems at Preschool Age: The Hokkaido Study on Environment and Children's Health.
    Minatoya M; Itoh S; Araki A; Tamura N; Yamazaki K; Miyashita C; Kishi R
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29324697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embryotoxic cytokines-Potential roles in embryo loss and fetal programming.
    Robertson SA; Chin PY; Femia JG; Brown HM
    J Reprod Immunol; 2018 Feb; 125():80-88. PubMed ID: 29306096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is fetal programming?: a lifetime health is under the control of in utero health.
    Kwon EJ; Kim YJ
    Obstet Gynecol Sci; 2017 Nov; 60(6):506-519. PubMed ID: 29184858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfer of maternal immunity and programming of the newborn immune system.
    Jennewein MF; Abu-Raya B; Jiang Y; Alter G; Marchant A
    Semin Immunopathol; 2017 Nov; 39(6):605-613. PubMed ID: 28971246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.